Advanced search
Publication Cover
Current Medical Research and Opinion Volume 22, 2006 - Issue 9
Submit an article Journal homepage
115
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Health economic impact of olopatadine compared to branded and generic sodium cromoglycate in the treatment of seasonal allergic conjunctivitis in the UK

Julian F. Guest CATALYST Health Economics Consultants, Northwood, UK; Postgraduate Medical School, University of Surrey, Guildford, UKCorrespondence[email protected]
,
John P. Clegg CATALYST Health Economics Consultants, Northwood, UK
&
Andrew F. Smith Health Economics Unit, Alcon Laboratories Ltd, Hemel Hempstead, UK; Nuffield Laboratory of Ophthalmology, University of Oxford, UK
Pages 1777-1785 | Accepted 12 Jun 2006, Published online: 03 Aug 2006

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Andrea Leonardi & Luigi Quintieri. (2010) Olopatadine: a drug for allergic conjunctivitis targeting the mast cell. Expert Opinion on Pharmacotherapy 11:6, pages 969-981.
Read now
Andrea Leonardi. (2007) New drug treatments for ocular allergies. Expert Review of Ophthalmology 2:3, pages 397-408.
Read now
William E Berger. (2007) Once-daily olopatadine ophthalmic solution 0.2% in the treatment of allergic conjunctivitis and rhinoconjunctivitis. Expert Review of Pharmacoeconomics & Outcomes Research 7:3, pages 221-226.
Read now

Articles from other publishers (4)

S Schmidt. (2021) Olopatadine in the management of allergic conjunctivitis. South African General Practitioner 2:5, pages 184-186.
Crossref
DoraHamad AlHarkan. (2020) Management of vernal keratoconjunctivitis in children in Saudi Arabia. Oman Journal of Ophthalmology 13:1, pages 3.
Crossref
Roisin Fitzsimons, Lauri-Ann van der Poel, William Thornhill, George du Toit, Neil Shah & Helen A Brough. (2015) Antihistamine use in children. Archives of disease in childhood - Education & practice edition 100:3, pages 122-131.
Crossref
. (2013) Olopatadine least costly in seasonal allergic conjunctivitis?. PharmacoEconomics & Outcomes News 515:1, pages 8-8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.